Royce & Associates’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $93K | Hold |
|
|||||
|
2022
Q2 | $150K | Hold |
|
|||||
|
2022
Q1 | $273K | Hold |
|
|||||
|
2021
Q4 | $701K | Hold |
|
|||||
|
2021
Q3 | $1.05M | Hold |
|
|||||
|
2021
Q2 | $1.34M | Hold |
|
|||||
|
2021
Q1 | $1.79M | Hold |
|
|||||
|
2020
Q4 | $2.05M | Hold |
|
|||||
|
2020
Q3 | $1.75M | Hold |
|
|||||
|
2020
Q2 | $2.41M | Hold |
|
|||||
|
2020
Q1 | $1.66M | Hold |
|
|||||
|
2019
Q4 | $1.79M | Hold |
|
|||||
|
2019
Q3 | $414K | Hold |
|
|||||
|
2019
Q2 | $343K | Hold |
|
|||||
|
2019
Q1 | $392K | Hold |
|
|||||
|
2018
Q4 | $314K | Hold |
|
|||||
|
2018
Q3 | $426K | Hold |
|
|||||
|
2018
Q2 | $385K | Hold |
|
|||||
|
2018
Q1 | $2.05M | Hold |
|
|||||
|
2017
Q4 | $1.71M | Hold |
|
|||||
|
2017
Q3 | $2.06M | Hold |
|
|||||
|
2017
Q2 | $2.05M | Hold |
|
|||||
|
2017
Q1 | $2.43M | Sell |
|
|||||
|
2016
Q4 | $2.63M | Sell |
|
|||||
|
2016
Q3 | $2.17M | Sell |
|
|||||
|
2016
Q2 | $1.21M | Buy |
|
|||||
|
2016
Q1 | $848K | Buy |
|
|||||
|
2015
Q4 | $232K | Hold |
|
|||||
|
2015
Q3 | $262K | Sell |
|
|||||
|
2015
Q2 | $783K | Hold |
|
|||||
|
2015
Q1 | $968K | Sell |
|
|||||
|
2014
Q4 | $978K | Buy |
|
|||||
|
2014
Q3 | $558K | Buy |
|